Studies show reductions in both systolic and diastolic blood pressure, while the medication's FDA approval for cardiovascular risk reduction highlights its importance in comprehensive health management
doi: 10.1016/j.clp.2017.10.007 29 ShiYAvatapalleHBSkaeMSPadidelaRNewbouldMRigbyLet al
The orally disintegrating tablet formulation offers unique administration considerations that distinguish it from traditional oral medications or injectable GLP-1 receptor agonists
The Bottom Line Retatrutide is doing something the obesity field hasnt seen before: it simultaneously outperforms every approved agent on weight loss, normalizes liver fat, improves glycemic control beyond existing diabetes therapies, eases osteoarthritis pain, and meaningfully reduces sleep apnea severity all without plateauing out to two years
By reducing body fat, semaglutide may indirectly improve how well your thyroid medication works and how energetic you feel overall
doi: 10.1007/s12325-022-02153-x